[Skip to the reading](/about#reading)

[Peptide Therapy News](/)

[Regulatory](/regulatory) [Research](/research)

[Archive](/#event-index) [About](/about)

Source review through 27 October 2026 · Event dates appear with reports

[Home](/) / About

# A place to catch up on peptide news

A study, an approval and a supply announcement can all make headlines. Peptide Therapy News helps you tell them apart.

## For the reader catching up

![Open heart-outcome and liver-fat research reprints with unreadable print and small tissue photographs.](/press-desk-66428b6910dc/about.webp)

Illustration: the research documents behind heart and liver headlines.

Peptide Therapy News covers a small set of research findings and U.S. regulatory decisions. It’s for anyone who has come across a peptide name and wants to understand the news behind it. There’s no need to arrive knowing the trial jargon.

Each report has two parts: what happened, then what it means. The first gives the finding or decision and links to the source. The second explains why it matters and where its reach ends. A result can be interesting without answering every treatment question.

## Why the dates get their own lines

An event date is the day of an announcement or decision. A source date tells you which version of the record the report uses. The source-review date is when the material was checked for this publication. Separating them helps you see how old the news is.

FDA’s peptide table is a good example. The page is current as of 22 April 2026, but it doesn’t give withdrawal dates for individual ingredients. That date is shown with the source. It isn’t used to guess when a particular request was taken back.

## The people in the study matter

A study of adults with one condition may not answer a question about people without it. The tesamorelin liver-fat study involved adults living with HIV. Its finding can’t simply be turned into a weight-loss claim for everyone. The report puts that context next to the result.

The links let you check the original records yourself. The [references page](/references) gathers the FDA notices, agency announcements and papers, with a short note on each. Older reports keep their event dates, so an earlier finding doesn’t look like news that just broke.

## Reading can help prepare a conversation

This publication gives no personal medical advice and sells nothing. It doesn’t prescribe, offer consultations or arrange treatment. Reading about a medicine can help you put a question into words. A licensed U.S. clinician can then consider that question alongside your own health history.

For a supply or compounding story, try the [regulatory page](/regulatory). For the retatrutide studies, head to [research](/research). The dated index on the home page connects related reports. The [contact page](/contact) explains where source questions and personal care questions belong, and why there is no medical inbox here.

## On this page

- [For the reader catching up](/about#reading-desk)

- [Why the dates get their own lines](/about#date-practice)

- [The people in the study matter](/about#finding-limits)

- [Reading can help prepare a conversation](/about#reading-on)

Source review 27 October 2026

[Open the source desk](/references) [Follow the event dates](/#event-index)

Peptide Therapy News is a guide for reading the record, not a clinic, pharmacy or seller.

© 2026 Peptide Therapy News

[References](/references) [About](/about) [Contact](/contact) [Event index](/#event-index)